Your browser doesn't support javascript.
loading
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019.
Solmi, Marco; Seitidis, Georgios; Mavridis, Dimitris; Correll, Christoph U; Dragioti, Elena; Guimond, Synthia; Tuominen, Lauri; Dargél, Aroldo; Carvalho, Andre F; Fornaro, Michele; Maes, Michael; Monaco, Francesco; Song, Minjin; Il Shin, Jae; Cortese, Samuele.
Afiliación
  • Solmi M; Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada. msolmi@toh.ca.
  • Seitidis G; On Track: The Champlain First Episode Psychosis Program, Department of Mental Health, The Ottawa Hospital, Ottawa, ON, Canada. msolmi@toh.ca.
  • Mavridis D; Ottawa Hospital Research Institute (OHRI) Clinical Epidemiology Program, University of Ottawa, Ottawa, ON, Canada. msolmi@toh.ca.
  • Correll CU; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. msolmi@toh.ca.
  • Dragioti E; Centre for Innovation in Mental Health (CIMH), School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK. msolmi@toh.ca.
  • Guimond S; Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany. msolmi@toh.ca.
  • Tuominen L; Department of Primary Education, Evidence Synthesis Methods Team, University of Ioannina, Ioannina, Greece.
  • Dargél A; Department of Primary Education, Evidence Synthesis Methods Team, University of Ioannina, Ioannina, Greece.
  • Carvalho AF; Faculté de Médecine, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
  • Fornaro M; Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Maes M; Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA.
  • Monaco F; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Song M; Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA.
  • Il Shin J; Pain and Rehabilitation Centre, and Department of Health, Medicine and Caring Sciences, Linkoping University, SE-581 85, Linkoping, Sweden.
  • Cortese S; Department of psychoeducation and psychology, University of Quebec in Outaouais, Gatineau, Canada.
Mol Psychiatry ; 2023 Jul 27.
Article en En | MEDLINE | ID: mdl-37500825
ABSTRACT
Schizophrenia substantially contributes to the burden of mental disorders. Schizophrenia's burden and epidemiological estimates in some countries have been published, but updated estimates of prevalence, incidence, and schizophrenia-related disability at the global level are lacking. Here, we present the data from and critically discuss the Global Burden of Diseases, Injuries, and Risk Factors Study data, focusing on temporal changes in schizophrenia's prevalence, incidence, and disability-adjusted life years (DALYs) globally. From 1990 to 2019, schizophrenia raw prevalence (14.2 to 23.6 million), incidence (941,000 to 1.3 million), and DALYs (9.1 to 15.1 million) increased by over 65%, 37%, and 65% respectively, while age-standardized estimates remained stable globally. In countries with high socio-demographic index (SDI), both prevalence and DALYs increased, while in those with low SDI, the age-standardized incidence decreased and DALYs remained stable. The male/female ratio of burden of schizophrenia has remained stable in the overall population over the past 30 years (i.e., M/F = 1.1), yet decreasing from younger to older age groups (raw prevalence in females higher than males after age 65, with males having earlier age of onset, and females longer life expectancy). Results of this work suggest that schizophrenia's raw prevalence, incidence, and burden have been increasing since 1990. Age-adjusted estimates did not reduce. Schizophrenia detection in low SDI countries is suboptimal, and its prevention/treatment in high SDI countries should be improved, considering its increasing prevalence. Schizophrenia sex ratio inverts throughout the lifespan, suggesting different age of onset and survival by sex. However, prevalence and burden estimates for schizophrenia are probably underestimated. GBD does not account for mortality from schizophrenia (and other mental disorders, apart from anorexia nervosa).

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Incidence_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Incidence_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá